Advanced Flower Capital (AFCG) Cash & Equivalents (2020 - 2026)

Advanced Flower Capital's Cash & Equivalents history runs 7 years deep, the most recent figure standing at $112.7 million for Q1 2026.

• On a quarterly basis, Cash & Equivalents rose 3297.25% year-over-year to $112.7 million in Q1 2026; TTM through Mar 2026 was $112.7 million, a 3297.25% increase from a year earlier, with the FY2025 full-year figure at $38.6 million, down 62.74% from the prior year.
• Cash & Equivalents climbed to $112.7 million in Q1 2026 per AFCG's latest filing, from $38.6 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $170.3 million in Q2 2024 and bottomed at $3.3 million in Q1 2025.
• The 5-year median for Cash & Equivalents is $80.6 million (2023), against an average of $76.1 million.
• Across the five-year window, Cash & Equivalents sank 98.0% in 2025 and jumped 3297.25% in 2026, its largest moves.
• Year by year, Cash & Equivalents stood at $140.4 million in 2022, then slumped by 35.61% to $90.4 million in 2023, then grew by 14.64% to $103.6 million in 2024, then plunged by 62.74% to $38.6 million in 2025, then soared by 192.01% to $112.7 million in 2026.
• Per Business Quant, the three latest AFCG Cash & Equivalents figures stand at $112.7 million (Q1 2026), $38.6 million (Q4 2025), and $45.1 million (Q3 2025).